Publications of W. Wurst
All genres
Journal Article (208)
141.
Journal Article
103 (37), pp. 13854 - 13859 (2006)
Lysosomal storage disease upon disruption of the neuronal chloride transport protein CIC-6. Proceedings of the National Academy of Sciences of the United States of America 142.
Journal Article
38 (9), pp. 967 - 969 (2006)
Iron homeostasis in the brain: complete iron regulatory protein 2 deficiency without symptomatic neurodegeneration in the mouse. Nature Genetics 143.
Journal Article
297 (1), pp. 141 - 157 (2006)
FGF regulated gene-expression and neuronal differentiation in the developing midbrain-hindbrain region. Developmental Biology 144.
Journal Article
575 (2), pp. 403 - 410 (2006)
Genetic networks controlling the development of midbrain dopaminergic neurons. Journal of Physiology-London 145.
Journal Article
377, pp. 65 - 76 (2006)
Molecular characterization, structure and developmental expression of Megane bHLH factor. Gene 146.
Journal Article
31 (2), pp. 293 - 302 (2006)
Altered dopaminergic innervation and amphetamine response in adult Otx2 conditional mutant mice. Molecular and Cellular Neuroscience 147.
Journal Article
34 (3), e25 (2006)
High-throughput trapping of secretory pathway genes in mouse embryonic stem cells. Nucleic Acids Research 148.
Journal Article
15 (6), pp. 551 - 552 (2006)
In vivo characterization of embryonic dopaminergic neurons derived from transgenic mice ectopically expressing Otx2 in the anterior hindbrain. Cell Transplantation 149.
Journal Article
133 (1), pp. 89 - 98 (2006)
A Wnt1-regulated genetic network controls the identity and fate of midbrain-dopaminergic progenitors in vivo. Development 150.
Journal Article
24, pp. 2291 - 2298 (2006)
Differential disinhibition of the neonatal hypothalamic-pituitary-adrenal axis in brain-specific CRH receptor 1-knockout mice. European Journal of Neuroscience 151.
Journal Article
43 (4), p. 216 - 216 (2005)
Progressive loss of the spongiotrophoblast layer of Birc6/Bruce mutants results in embryonic lethality (vol 42, pg 91, 2005). Genesis 152.
Journal Article
38 (5), p. 232 - 232 (2005)
CRHR-1 signalling inhibits AMPA-receptor internalisation. Pharmacopsychiatry 153.
Journal Article
38 (5), p. 236 - 236 (2005)
Gene expression profiling reveals corticotropin-releasing hormone (CRH) dependent signaling pathways. Pharmacopsychiatry 154.
Journal Article
38 (5), p. 261 - 261 (2005)
Site-specific overexpression of corticotropin-releasing hormone (CRH) in the mouse brain - modelling central CRH system hyperactivity. Pharmacopsychiatry 155.
Journal Article
94 (Suppl. 2), p. 230 - 230 (2005)
Conditional Crh1 receptor knockout mice show altered neuronal activation pattern to mild anxiogenic challenge. Journal of Neurochemistry 156.
Journal Article
233 (3), pp. 1023 - 1030 (2005)
Expression of Fgf receptors 1, 2, and 3 in the developing mid- and hindbrain of the mouse. Developmental Dynamics 157.
Journal Article
2 (6), pp. 403 - 404 (2005)
Introducing the German Mouse Clinic: open access platform for standardized phenotyping. Nature Methods 158.
Journal Article
42 (2), pp. 91 - 103 (2005)
Progressive loss of the spongiotrophoblast layer of Birc6/Bruce mutants results in embryonic lethality. Genesis 159.
Journal Article
102 (17), pp. 6183 - 6188 (2005)
Corticotropin-releasing hormone activates ERK1/2 MAPK in specific brain areas. Proceedings of the National Academy of Sciences of the United States of America 160.
Journal Article
25 (5), pp. 1980 - 1988 (2005)
Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development. Molecular and Cellular Biology